Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03141255 · ClinicalTrials.gov registry record · NA
Cardiogenic Shock Intravascular Cooling Trial
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT03141255 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 20 participants.
The verdict
NCT03141255, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of the study is to compare patients with cardiogenic shock who receive standard therapy plus therapeutic hypothermia (TH) to patients with cardiogenic shock who receive standard medical therapy alone in order to assess the safety of TH in patients with cardiogenic shock. This study will also help understand the physiologic effects of TH in patients with cardiogenic shock. This will be a pilot study to establish the initial safety of TH and to assess tolerability of TH in this patient population.
Interventions
- DEVICE IVTM™ System
- DEVICE Quattro® Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-11-06 |
| Est. Completion | 2021-11-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03141255
The ClinicalTrials.gov registry entry for NCT03141255 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which IVTM™ System is the first listed.
NCT03141255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03141255 about?
NCT03141255 is a clinical study titled "Cardiogenic Shock Intravascular Cooling Trial". The purpose of the study is to compare patients with cardiogenic shock who receive standard therapy plus therapeutic hypothermia (TH) to patients with cardiogenic shock who receive standard medical therapy alone in order to assess the safety of TH in patients with cardiogenic shock. This study will ...
What is the current status of trial NCT03141255?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-11-06. Estimated completion is 2021-11-01.
What interventions are being tested in trial NCT03141255?
The interventions under investigation include: IVTM™ System (DEVICE), Quattro® Catheter (DEVICE).
Who is sponsoring clinical trial NCT03141255?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.